Study on influence of drugs on antiplatelet effects of aspirin.

Study on influence of drugs on antiplatelet effects of aspirin. - Study on influence of drugs on antiplatelet effects of aspirin.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010881

Enrollment

Registered

2013-06-05

Start date

2013-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Healthy volunteers. 2)Subjects who signed, based on his/her free will, to the clinical trial agreement with full understanding of the purpose of this conducted trial and its insights.

Exclusion criteria

Exclusion criteria: 1)Subjects who have donated 200 mL blood within 1 month, or 400 mL blood within 3 month. 2)Subjects who have taken aspirin or drugs with antiplatelet effect within 1 week. 3)Subjects with hypertension or hypotension. 4)Subjects with poor condition on a blood collecting day. 5)Subjects whom the doctor considered to be unsuitable for this study. 6)Subjects who are unable to put restrictions on diets (ex. foods and drinks are prohibited within 4 hours prior to blood collection, high fat meals should be avoided since 1 day before blood collection).

Design outcomes

Primary

Measure	Time frame
Platelet aggregation activity(Platelet Aggregation Threshold Index:PATI)	—

Secondary

Measure	Time frame
Serum thromboxane B2 concentration	—

Countries

Japan

Contacts

Public ContactTakao Aoyama

Tokyo University of Science Faculty of Pharmaceutical Sciences

t-aoyama@rs.noda.tus.ac.jp04-7121-3659

Outcome results